Publications by authors named "Rob Jansen"

Claim this Profile
D
Discovering novel germline genetic variants linked to severe fluoropyrimidine-related toxicity in- and outside DPYD.
Jonathan E Knikman, Qinglian Zhai, Carin A T C Lunenburg, Linda M Henricks, Stefan Böhringer, Rob L H Jansen

Genome Med· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk factors for cancer of unknown primary: a literature review.
Karlijn E P E Hermans, Fatemeh Kazemzadeh, Caroline Loef, Rob L H Jansen, Iris D Nagtegaal

BMC Cancer· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Type 2 diabetes mellitus and cancer of unknown primary risk: results from the Netherlands Cohort Study.
Karlijn E P E Hermans, Sharmi Haque, Piet A van den Brandt, Caroline Loef, Rob L H Jansen

Eur J Cancer Prev· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vegetable and fruit consumption and cancer of unknown primary risk: results from the Netherlands cohort study on diet and cancer.
Karlijn E P E Hermans, Piet A van den Brandt, Caroline Loef, Rob L H Jansen, Leo J Schouten

BMC Cancer· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adherence to the World Cancer Research Fund and the American Institute for Cancer Research lifestyle recommendations for cancer prevention and Cancer of Unknown Primary risk.
Karlijn E P E Hermans, Piet A van den Brandt, Caroline Loef, Rob L H Jansen, Leo J Schouten

Clin Nutr· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Meat consumption and cancer of unknown primary (CUP) risk: results from The Netherlands cohort study on diet and cancer.
Karlijn E P E Hermans, Piet A van den Brandt, Caroline Loef, Rob L H Jansen, Leo J Schouten

Eur J Nutr· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Family history of cancer in first degree relatives and risk of cancer of unknown primary.
Alexander L R Grewcock, Karlijn E P E Hermans, Matty P Weijenberg, Piet A van den Brandt, Caroline Loef, Rob L H Jansen

Eur J Cancer Care (Engl)· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alcohol consumption, cigarette smoking and cancer of unknown primary risk: Results from the Netherlands Cohort Study.
Karlijn E P E Hermans, Piet A van den Brandt, Caroline Loef, Rob L H Jansen, Leo J Schouten

Int J Cancer· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anthropometry, physical activity and cancer of unknown primary (CUP) risk: Results from the Netherlands cohort study.
Karlijn E P E Hermans, Piet A van den Brandt, Caroline Loef, Rob L H Jansen, Leo J Schouten

Cancer Epidemiol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Commutability of proficiency testing material containing amitriptyline and nortriptyline: A study within the framework of the Dutch Calibration 2.000 project.
Karen Robijns, Niels W Boone, Rob T P Jansen, Aldy W H M Kuypers, Cees Neef

Clin Chim Acta· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Favourable course of cancer of unknown primary].
A J van de Wouw, A M W van Marion, Rob L H Jansen

Ned Tijdschr Geneeskd· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biomarker results from a phase II study of MEK1/2 inhibitor binimetinib (MEK162) in patients with advanced - or -mutated melanoma.
Carla M L van Herpen, Sanjiv S Agarwala, Axel Hauschild, Carola Berking, J Thaddeus Beck, Rob Jansen

Oncotarget· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A cost analysis of upfront DPYD genotype-guided dose individualisation in fluoropyrimidine-based anticancer therapy.
Linda M Henricks, Carin A T C Lunenburg, Femke M de Man, Didier Meulendijks, Geert W J Frederix, Rob L H Jansen

Eur J Cancer· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DPYD genotype-guided dose individualisation of fluoropyrimidine therapy in patients with cancer: a prospective safety analysis.
Linda M Henricks, Carin A T C Lunenburg, Femke M de Man, Didier Meulendijks, Geert W J Frederix, Rob L H Jansen

Lancet Oncol· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The quest for equivalence of test results: the pilgrimage of the Dutch Calibration 2.000 program for metrological traceability.
Rob T P Jansen, Christa M Cobbaert, Cas Weykamp, Marc Thelen

Clin Chem Lab Med· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A design for external quality assessment for the analysis of thiopurine drugs: pitfalls and opportunities.
Karen Robijns, Matthijs van Luin, Rob T P Jansen, Cees Neef, Daan J Touw

Clin Chem Lab Med· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Herpes Encephalitis: A Mortal Complication in a Patient Treated with Immunosuppressive Drugs because of Immune-Related Adverse Events after Ipilimumab Treatment.
Lieke van Montfort, Caroline M Loos, Monique Anten, Rob L H Jansen

Case Rep Oncol· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expressing analytical performance from multi-sample evaluation in laboratory EQA.
Marc H M Thelen, Rob T P Jansen, Cas W Weykamp, Herman Steigstra, Ron Meijer

Clin Chem Lab Med· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Severe fluoropyrimidine toxicity due to novel and rare DPYD missense mutations, deletion and genomic amplification affecting DPD activity and mRNA splicing.
André B P van Kuilenburg, Judith Meijer, Dirk Maurer, Doreen Dobritzsch, Rutger Meinsma, Rob L H Jansen

Biochim Biophys Acta Mol Basis Dis· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Commutability of proficiency testing material containing tobramycin: a study within the framework of the Dutch Calibration 2.000 project.
Karen Robijns, Niels W Boone, Rob T P Jansen, Aldy W H M Kuypers, Cees Neef

Clin Chem Lab Med· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of Systemic Therapy Concurrent With Cranial Radiotherapy for Cerebral Metastases of Solid Tumors.
Maikel Verduin, Jaap D Zindler, Hanneke M A Martinussen, Rob L H Jansen, Sander Croes

Oncologist· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Highly sensitive miniature fluidic flowmeter based on an FBG heated by Co-doped fiber.
Zhengyong Liu, Lin Htein, Lun-Kai Cheng, Quincy Martina, Rob Jansen

Opt Express· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term Outcome of an Organ Preservation Program After Neoadjuvant Treatment for Rectal Cancer.
Milou H Martens, Monique Maas, Luc A Heijnen, Doenja M J Lambregts, Jeroen W A Leijtens, Rob Jansen

J Natl Cancer Inst· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I-II study on the combination of rapamycin and short course radiotherapy in rectal cancer.
Jeroen Buijsen, Jørgen van den Bogaard, Barry Jutten, Eric Belgers, Meindert Sosef, Rob L H Jansen

Radiother Oncol· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neo-adjuvant chemotherapy followed by surgery versus surgery alone in high-risk patients with resectable colorectal liver metastases: the CHARISMA randomized multicenter clinical trial.
Ninos Ayez, Eric P van der Stok, Hans de Wilt, Sandra A Radema, Richard van Hillegersberg, Rob L Jansen

BMC Cancer· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis